News
Baxter and Hospira recalls December 2013/January 2014

Baxter and Hospira recalls

Baxter Recalls Clinimix and ClinimixE

January 3rd, 2014

Baxter has initiated a voluntary recall of two lots of CLINIMIX and one lot of CLINIMIX E Injection parenteral nutrition products to the user level due to complaints of particulate matter found in the products.  The affected lots [2B7729 (lot P287045, exp 06/14), 2B7717 (lot P275883, exp 10/13) and 2B7709 (lot P285122, exp 05/14)] were distributed to customers between May 2012 and October 2013.

Unaffected lot numbers can continue to be used according to the instructions for use.

Additional details are found in the FDA listing

 

Baxter Recalls 5% Dextrose Injection and 0.9% Sodium Chloride Injection

December 23, 2013

Baxter has initiated a voluntary recall to the hospital/user level of one lot of 5% Dextrose Injection, USP and four lots of 0.9% Sodium Chloride Injection, USP due to particulate matter found in the solutions. The affected lots [2B0089 (lot P285288, exp 11/13), 2B1308 (lot P297283, exp 08/14), 2B1302 (lot P292326. Exp 04/14 and P293993, exp 05/14), and 2B1309 (lot P293514, exp 04/14)] were distributed to customers between May 2012 and October 2013.

Unaffected lot numbers can continue to be used according to the instructions for use.

Additional details are found in this FDA Listing.

 Hospira Recalls Lidocaine HCl Injection

December 23, 2013

Hospira initiated a voluntary nationwide recall to the user level for one lot of Lidocaine HCl Injection, USP, 2%, 5 mL Single-Dose Vial (NDC 0409-2066-05), Lot 32-135-DD, expiration date 1AUG2015.

The recall is due to a reddish orange particulate on the inner surface and floating in the solution.

Additional information is found in this FDA Listing.